-
Signature
-
/s/ Richard Steinhart, as Attorney in Fact for Vimal Mehta, Ph.D.
-
Stock symbol
-
BTAI
-
Transactions as of
-
Dec 14, 2024
-
Transactions value $
-
-$1,131
-
Form type
-
4
-
Date filed
-
12/17/2024, 06:08 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
BTAI |
Common Stock |
Options Exercise |
|
+2.61K |
+4.68% |
|
58.4K |
Dec 14, 2024 |
Direct |
F1 |
transaction |
BTAI |
Common Stock |
Options Exercise |
|
+3.5K |
+5.99% |
|
61.9K |
Dec 15, 2024 |
Direct |
F1 |
transaction |
BTAI |
Common Stock |
Sale |
-$358 |
-983 |
-1.59% |
$0.36 |
60.9K |
Dec 16, 2024 |
Direct |
F2, F3 |
transaction |
BTAI |
Common Stock |
Sale |
-$773 |
-2.13K |
-3.46% |
$0.36 |
59.6K |
Dec 16, 2024 |
Direct |
F2, F3 |
holding |
BTAI |
Common Stock |
|
|
|
|
|
2K |
Dec 14, 2024 |
By spouse |
|
holding |
BTAI |
Common Stock |
|
|
|
|
|
7.69M |
Dec 14, 2024 |
By BioXcel LLC |
F4 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
BTAI |
Restricted Stock Units |
Options Exercise |
$0 |
-2.61K |
-16.67% |
$0.00 |
13K |
Dec 14, 2024 |
Common Stock |
2.61K |
|
Direct |
F1, F5 |
transaction |
BTAI |
Restricted Stock Units |
Options Exercise |
$0 |
-3.5K |
-10% |
$0.00 |
31.5K |
Dec 15, 2024 |
Common Stock |
3.5K |
|
Direct |
F1, F6 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: